Effects of androgen suppression therapy on the incidence and prognosis of bladder cancer: An updated systematic review and meta-analysis

Y Wang, Y Song, Y Peng, S Han, C Qin, Y Du… - … Oncology: Seminars and …, 2024 - Elsevier
Introduction The influence of androgen suppression therapy (AST) on bladder cancer (BCa)
remains controversial, as recent studies have not reached a consensus regarding the …

Profiling steroid hormone landscape of bladder cancer reveals depletion of intratumoural androgens to castration levels: a cross-sectional study

K Kettunen, J Mathlin, T Lamminen, A Laiho… - Ebiomedicine, 2024 - thelancet.com
Background Bladder cancer is a highly over-represented disease in males. The involvement
of sex steroids in bladder carcinogenesis and the utilisation of steroid hormone action as a …

Correlation between androgen and estrogen receptor expression and clinicopathologic features in carcinoma urinary bladder

N Shrivastava, R Jena, GR Choudhary… - Journal of Cancer …, 2023 - Springer
Introduction The molecular map** of cancers by the Cancer Genome Atlas Project has
accelerated the quest for new therapeutic targets for urinary bladder cancer, including sex …

The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational …

JH Pyun, NH Son, YH Ko, SW Kim… - The World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Purpose To investigate the long-term effects of taking 5-alpha reductase inhibitors (5ARIs)
on the development of bladder cancer (BC) and the implementation of radical cystectomy …

[HTML][HTML] Testosterone and 5 Alpha Reductase Inhibitor (5ARI) in Benign Prostatic Hyperplasia (BPH): A historical perspective

AC Diokno, A Kunta, R Bowen - Continence, 2024 - Elsevier
This paper provides a review of the historical and scientific evolution of testosterone and
5ARI research. It chronicles the evolution from early empirical practices like castration …